A comparative analysis of assisted reproductive technology cycles in Australia and New Zealand 2004-2007

Human Reproduction
C M FarquharElizabeth Sullivan

Abstract

There are different funding arrangements for fertility treatments between New Zealand (NZ) and Australia. In NZ, there are two options for patients accessing treatment: either meeting specified criteria for age, no smoking and BMI for publicly funding or funding their own treatment. This differs from Australia, which has no explicit eligibility criteria restricting access to fertility treatment. An analysis of assisted reproductive technology (ART) in Australia and NZ was undertaken to consider the impact of these different funding approaches. Data were extracted from the Australian and New Zealand Assisted Reproduction Database between 2004 and 2007. A total of 116 111 autologous fresh cycles were included. In Australia, more cycles were in women aged 40 years or older compared with those in NZ (23.5 versus 16.0%, P < 0.01). Single embryo transfer was more common in NZ than that in Australia, in women < 35 years of age (75.1 versus 59.6%, P < 0.01). In women <35 years, the crude rates of clinical pregnancy (37.5 versus 31.2%, P < 0.01) and live delivery (31.6 versus 26%, P < 0.01) following fresh ART cycles were significantly higher in NZ than that in Australia. These differences in outcomes persisted in older age groups. The ...Continue Reading

References

Jan 11, 1997·BMJ : British Medical Journal·D C Hadorn, A C Holmes
Feb 24, 2006·The Medical Journal of Australia·Georgina M ChambersElizabeth A Sullivan
Jul 22, 2006·BJOG : an International Journal of Obstetrics and Gynaecology·W R GillettC M Farquhar
Jun 2, 2009·Fertility and Sterility·Georgina M ChambersG David Adamson

❮ Previous
Next ❯

Citations

Jan 5, 2013·Journal of Bioethical Inquiry·Drew CarterUNKNOWN ASTUTE Health study group
Aug 4, 2012·Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies·Christie E BolchJane R W Fisher
Nov 4, 2011·Human Reproduction·Deborah PayneGuy Gudex
Jun 17, 2014·Seminars in Fetal & Neonatal Medicine·Georgina M Chambers, William Ledger
Aug 3, 2013·Fertility and Sterility·Georgina M ChambersMarinus J C Eijkemans
Oct 10, 2012·Fertility and Sterility·Lois A SalamonsenNatalie J Hannan
Feb 3, 2012·Reproductive Biomedicine Online·John YovichPeter Hinchliffe
Sep 14, 2010·Reproductive Biomedicine Online·James D StangerGhanim Almahbobi
May 1, 2012·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Gabor T KovacsJulian McCrann
Oct 13, 2011·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Barbro FridénJudith Menezes
Jul 12, 2016·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Sumita BaruaMark McLean
Feb 26, 2013·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Mark P UmstadElizabeth A Sullivan
Jan 24, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·G K DinhamA W Shand
Jul 14, 2010·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Georgina M ChambersMichael G Chapman
Oct 24, 2019·Human Fertility : Journal of the British Fertility Society·Jacob NethertonMark Baker
Aug 3, 2017·The Medical Journal of Australia·Georgina M ChambersLouisa Jorm
Feb 18, 2021·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Sarah LensenKarin Hammarberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.